Switzerland· 66834002
Biktarvy
A emtricitabine, tenofovir alafenamide and bictegravir product containing bictegravirum, emtricitabinum, tenofovirum alafenamidum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide and bictegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR20 (emtricitabine, tenofovir alafenamide and bictegravir), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide and bictegravir · ATC J05AR20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- bictegravirum, emtricitabinum, tenofovirum alafenamidum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AR20
- ATC class
- Emtricitabine, tenofovir alafenamide and bictegravir
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680668340026Blist 30 StkCHF 1110.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide and bictegravir in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBiktarvyGilead Sciences, Inc.
- FinlandBiktarvyGilead Sciences Ireland UC
- CzechiaBIKTARVYGilead Sciences Ireland UC, Carrigtohill
- SpainBIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGilead Sciences Ireland Unlimited Company
- United KingdomBiktarvy 30mg/120mg/15mg tabletsGilead Sciences Ltd
- FranceBIKTARVY 30 mg/120 mg/15 mg, comprimé pelliculéGILEAD SCIENCES IRELAND UC (IRLANDE)
- PolandBiktarvyGilead Sciences Ireland UC
- SwedenBiktarvy 30 mg/120 mg/15 mg Filmdragerad tablettGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Biktarvy
- Liechtenstein · Biktarvy
- Norway · Biktarvy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba92a344-e19b-4795-846e-1b2343dc2e6f GET /v1/drugs/ba92a344-e19b-4795-846e-1b2343dc2e6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "bictegravirum 50 mg + emtricitabinum 200 mg + tenofovirum alafenamidum 25 mg",
"valid_from": "2022-07-01",
"limitations": null,
"galenic_form": "Filmtabl 50/200/25mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-07-01",
"self_retention_pct": 10
}See everything about emtricitabine, tenofovir alafenamide and bictegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.